DK199783D0 - Immunoglobulin-halvmolekyler og fremgangsmade til fremstilling af hybrid-antistoffer - Google Patents

Immunoglobulin-halvmolekyler og fremgangsmade til fremstilling af hybrid-antistoffer

Info

Publication number
DK199783D0
DK199783D0 DK1997/83A DK199783A DK199783D0 DK 199783 D0 DK199783 D0 DK 199783D0 DK 1997/83 A DK1997/83 A DK 1997/83A DK 199783 A DK199783 A DK 199783A DK 199783 D0 DK199783 D0 DK 199783D0
Authority
DK
Denmark
Prior art keywords
immunoglobulin
molecules
procedures
semi
preparation
Prior art date
Application number
DK1997/83A
Other languages
English (en)
Other versions
DK199783A (da
Inventor
Karen Auditore-Hargreaves
Frederick Miesowicz
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/374,970 external-priority patent/US4446233A/en
Priority claimed from US06/374,971 external-priority patent/US4479895A/en
Application filed by Du Pont filed Critical Du Pont
Publication of DK199783D0 publication Critical patent/DK199783D0/da
Publication of DK199783A publication Critical patent/DK199783A/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK199783A 1982-05-05 1983-05-04 Immunoglobulin-halvmolekyler og fremgangsmaade til fremstilling af hybrid-antistoffer DK199783A (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US37497182 1982-05-05
US06/374,970 US4446233A (en) 1982-05-05 1982-05-05 Homogeneous immunoassay using covalent hybrid antibodies
US37497082 1982-05-05
US06/374,971 US4479895A (en) 1982-05-05 1982-05-05 Immunoglobulin half-molecules and process for producing hybrid antibodies

Publications (2)

Publication Number Publication Date
DK199783D0 true DK199783D0 (da) 1983-05-04
DK199783A DK199783A (da) 1983-11-06

Family

ID=27006845

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199783A DK199783A (da) 1982-05-05 1983-05-04 Immunoglobulin-halvmolekyler og fremgangsmaade til fremstilling af hybrid-antistoffer

Country Status (5)

Country Link
EP (1) EP0096463B1 (da)
JP (1) JPH05295000A (da)
CA (1) CA1194415A (da)
DE (1) DE3368064D1 (da)
DK (1) DK199783A (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004811A1 (en) * 1984-04-23 1985-11-07 Boston Biomedical Research Institute, Inc. Bispecific antibody determinants
NL8501219A (nl) * 1985-04-29 1986-11-17 Stichting Vrienden Van De Stic Immunologisch complex, de bereiding en toepassing daarvan.
US4954617A (en) * 1986-07-07 1990-09-04 Trustees Of Dartmouth College Monoclonal antibodies to FC receptors for immunoglobulin G on human mononuclear phagocytes
GB8626767D0 (en) * 1986-11-10 1986-12-10 Unilever Plc Assays
US5086002A (en) * 1987-09-07 1992-02-04 Agen Biomedical, Ltd. Erythrocyte agglutination assay
IL87768A (en) * 1987-09-17 1994-12-29 Agen Ltd Blood assay including erythrocyte agglutination and reagent for the assay comprising conjugate of erythrocyte binding molecule and analyte binding molecule
IT1235349B (it) * 1988-12-23 1992-06-30 Biodata Spa Saggio immunologico per determinazioni in fase omogenea
AU665758B2 (en) * 1991-04-26 1996-01-18 Surface Active Limited Novel antibodies, and methods for their use
US5447846A (en) * 1992-07-17 1995-09-05 Fuji Photo Film C., Ltd. Homogeneous Immunoassay process using covalent conjugate of enzyme and plural monoclonal antibodies for different epitopes on analyte
GB9316369D0 (en) * 1993-08-06 1993-09-22 Surface Active Ltd Diagnostic method
JP2005172694A (ja) * 2003-12-12 2005-06-30 Fuji Photo Film Co Ltd タンパク質の検出方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2508132C3 (de) * 1974-03-08 1980-10-16 Teijin Ltd., Osaka (Japan) Verfahren zur Herstellung von Humanimmunglobulin-Derivaten und parenteral applizierbare Lösung hiervon
US4156081A (en) * 1977-04-15 1979-05-22 Syva Company Theophylline antigens and antibodies
AU556548B2 (en) * 1980-03-03 1986-11-06 Milton David Goldenberg Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor-associated markers
DE3134361A1 (de) * 1981-08-31 1983-03-10 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur enzymimmuno-bestimmung in homogener phase

Also Published As

Publication number Publication date
CA1194415A (en) 1985-10-01
DK199783A (da) 1983-11-06
DE3368064D1 (en) 1987-01-15
JPH05295000A (ja) 1993-11-09
EP0096463B1 (en) 1986-12-03
EP0096463A1 (en) 1983-12-21

Similar Documents

Publication Publication Date Title
DK23183A (da) Fremgangsmaade til fremstilling af humane monoclonale antistoffer
DK113083D0 (da) Fremgangsmade til fremstilling af et antistofkonjugat
DK159597C (da) Fremgangsmaade til formning af beholdere
DK1183D0 (da) Fremgangsmade til fremstilling af tiazolidinderivater
DE3167698D1 (en) Method for the determination of antigens with the aid of two or more monoclonal antibodies
DK159824C (da) Analogifremgangsmaade til fremstilling af succinylferroproteiner
ES527730A0 (es) Anticuerpos monoclonales
DK372283D0 (da) Fremgangsmade til fremstilling af desoxyuridinderivater
DK265584D0 (da) Fremgangsmaade til fremstilling af proteinkoncentrater
DK135283D0 (da) Fremgangsmade til fremstilling af et jernkompleks
DK199783D0 (da) Immunoglobulin-halvmolekyler og fremgangsmade til fremstilling af hybrid-antistoffer
DK355483A (da) Monoklonale antistoffer til krydsafstemning af humant vaev
DK157367C (da) Fremgangsmaade til fremstilling af intravenoest administrerbart humant immunoglobulin
DK309783A (da) Fremgangsmaade til fremstilling af organoglykosider
DK340383D0 (da) Monoklone igm-antistoffer og fremgangsmade til deres fremstilling
DK119083D0 (da) Fremgangsmade til fremstilling af alkanoylpyridinoner
DK159421C (da) Fremgangsmaade til fremstilling af trifluormethylpyridiner
DK47684A (da) Fremgangsmaade til fremstilling af proteinhydrolysater
DK424083A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK33181A (da) Fremgangsmaade til fremstilling af et interferonlignende protein
DK296383D0 (da) Fremgangsmade til fremstilling af fenaetylaminer
NO833655L (no) Fremgangsmaate for fremstilling av antigen
DK273183D0 (da) Fremgangsmade til fremstilling af amidiner
DK62283A (da) Fremgangsmaade til fremstilling af peptidergotalkaloider
DK219483A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment